Influence of the HER receptor ligand system on sensitivity to cetuximab and trastuzumab in gastric cancer cell lines.
Julia KneisslAnja HartmannNicole PfarrFranziska ErlmeierThomas LorberSimone KellerGwen ZwingenbergerWilko WeichertBirgit LuberPublished in: Journal of cancer research and clinical oncology (2016)
Our data indicate that HB-EGF may be a useful marker for the prediction of trastuzumab sensitivity in gastric cancer.